Spring Creek Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Spring Creek Capital’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-82,500	Closed	-$8M	–	26
2019 Q3	$8M	Sell	82,500 -43,500	-35%	-$4.36M	3.82%	10
2019 Q2	$12.9M	Sell	126,000 -74,000	-37%	-$7.99M	4.65%	10
2019 Q1	$22.8M	Buy	+200,000	New	+$14.7M	12.1%	3

Spring Creek Capital's ONCE Position: Q4 2019 in Review

Spring Creek Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 82,500 shares — an estimated $8M sold.

Spring Creek Capital first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $22.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Spring Creek Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Spring Creek Capital sold 82,500 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $8M.
Spring Creek Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Spring Creek Capital's Spark Therapeutics, Inc. Common Stock position peaked at $22.8M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Spring Creek Capital's 13F filing for Q4 2019, filed 13 Feb 2020.